Popular Diabetes and Weight-Loss Drug May Reduce Risk of Alzheimer’s Disease

Researchers at the Case Western Reserve School of Medicine have found that semaglutide may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D). 

Read More